Have your own idea? Try our Stock Screener
Pakistani (KSE) Healthcare Sector Analysis
UpdatedNov 21, 2024
DataAggregated Company Financials
Companies14
- 7D2.2%
- 3M63.4%
- 1Y125.5%
- YTD118.0%
Over the last 7 days, the Healthcare industry has risen 5.3%, driven by gains in BF Biosciences and Abbott Laboratories (Pakistan) of 53% and 2.8%, respectively. This takes the industry's 12 month performance to a gain of 137%.
Sector Valuation and Performance
Has the Pakistani Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | PK₨439.9b | PK₨287.7b | PK₨20.8b | 20.5x | 21.1x | 1.5x |
| Sat, 19 Oct 2024 | PK₨318.7b | PK₨273.9b | PK₨16.7b | 18.2x | 19.1x | 1.2x |
| Mon, 16 Sep 2024 | PK₨285.8b | PK₨280.5b | PK₨13.7b | 12.9x | 20.8x | 1x |
| Wed, 14 Aug 2024 | PK₨259.3b | PK₨272.9b | PK₨9.7b | 14.6x | 26.8x | 1x |
| Fri, 12 Jul 2024 | PK₨271.3b | PK₨272.9b | PK₨9.7b | 14.2x | 28.1x | 1x |
| Sun, 09 Jun 2024 | PK₨241.3b | PK₨268.3b | PK₨9.5b | 13.9x | 25.3x | 0.9x |
| Tue, 07 May 2024 | PK₨206.1b | PK₨263.7b | PK₨10.4b | 13.5x | 19.7x | 0.8x |
| Thu, 04 Apr 2024 | PK₨185.6b | PK₨255.3b | PK₨9.1b | 16.7x | 20.4x | 0.7x |
| Sat, 02 Mar 2024 | PK₨188.2b | PK₨250.0b | PK₨7.9b | 12.9x | 23.8x | 0.8x |
| Mon, 29 Jan 2024 | PK₨178.5b | PK₨248.2b | PK₨7.9b | 12.9x | 22.7x | 0.7x |
| Wed, 27 Dec 2023 | PK₨173.1b | PK₨248.2b | PK₨7.9b | 12.9x | 22x | 0.7x |
| Fri, 24 Nov 2023 | PK₨189.1b | PK₨245.1b | PK₨7.8b | 14.4x | 24.3x | 0.8x |
| Sun, 22 Oct 2023 | PK₨153.1b | PK₨237.4b | PK₨8.2b | 12.8x | 18.7x | 0.6x |
| Tue, 19 Sep 2023 | PK₨136.2b | PK₨234.0b | PK₨9.9b | 10.4x | 13.7x | 0.6x |
| Thu, 17 Aug 2023 | PK₨154.6b | PK₨230.3b | PK₨10.4b | 12.3x | 14.8x | 0.7x |
| Sat, 15 Jul 2023 | PK₨160.4b | PK₨230.3b | PK₨10.4b | 12.9x | 15.4x | 0.7x |
| Mon, 12 Jun 2023 | PK₨151.5b | PK₨230.3b | PK₨10.4b | 11.6x | 14.5x | 0.7x |
| Wed, 10 May 2023 | PK₨153.5b | PK₨218.4b | PK₨14.3b | 10.9x | 10.7x | 0.7x |
| Fri, 07 Apr 2023 | PK₨157.0b | PK₨214.8b | PK₨16.5b | 9.1x | 9.5x | 0.7x |
| Sun, 05 Mar 2023 | PK₨157.9b | PK₨212.7b | PK₨16.6b | 8.6x | 9.5x | 0.7x |
| Tue, 31 Jan 2023 | PK₨148.8b | PK₨211.8b | PK₨16.8b | 8.2x | 8.8x | 0.7x |
| Thu, 29 Dec 2022 | PK₨172.7b | PK₨210.9b | PK₨16.9b | 9.2x | 10.2x | 0.8x |
| Sat, 26 Nov 2022 | PK₨207.9b | PK₨210.0b | PK₨16.6b | 11.3x | 12.5x | 1x |
| Mon, 24 Oct 2022 | PK₨215.2b | PK₨202.2b | PK₨18.9b | 11.3x | 11.4x | 1.1x |
| Wed, 21 Sep 2022 | PK₨215.0b | PK₨193.0b | PK₨20.1b | 10x | 10.7x | 1.1x |
| Fri, 19 Aug 2022 | PK₨238.4b | PK₨189.9b | PK₨23.3b | 10x | 10.3x | 1.3x |
| Sun, 17 Jul 2022 | PK₨235.2b | PK₨188.5b | PK₨23.1b | 9.9x | 10.2x | 1.2x |
| Tue, 14 Jun 2022 | PK₨232.5b | PK₨185.8b | PK₨23.1b | 9.4x | 10.1x | 1.3x |
| Thu, 12 May 2022 | PK₨233.3b | PK₨184.3b | PK₨22.9b | 9.5x | 10.2x | 1.3x |
| Sat, 09 Apr 2022 | PK₨251.4b | PK₨182.8b | PK₨22.9b | 10.4x | 11x | 1.4x |
| Mon, 07 Mar 2022 | PK₨254.9b | PK₨180.0b | PK₨21.1b | 11.6x | 12.1x | 1.4x |
| Wed, 02 Feb 2022 | PK₨266.0b | PK₨180.0b | PK₨21.5b | 11.8x | 12.4x | 1.5x |
| Fri, 31 Dec 2021 | PK₨268.4b | PK₨180.0b | PK₨21.5b | 12x | 12.5x | 1.5x |
| Sun, 28 Nov 2021 | PK₨267.7b | PK₨179.9b | PK₨21.5b | 12.2x | 12.5x | 1.5x |
Price to Earnings Ratio
12.5x
Current Industry PE
- Investors are optimistic on the Pakistani Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 21.5x which is higher than its 3-year average PE of 15.9x.
- The 3-year average PS ratio of 0.97x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Pakistani Healthcare sector?
| PK Market | 2.07% | |
| Healthcare | 2.22% | |
| Life Sciences | 13.99% | |
| Healthcare Services | 2.72% | |
| Pharma | 1.93% | |
| Medical Equipment | 0% | |
| Healthtech | 0% | |
| Biotech | 0% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 47.1x.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Healthcare Services industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 8.7x.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BFBIO BF Biosciences | PK₨149.90 | 52.8% +PK₨3.3b | n/a | PE23.7x | |
| ABOT Abbott Laboratories (Pakistan) | PK₨1.05k | 2.8% +PK₨2.8b | 131.6% | PE20.5x | |
| AGP AGP | PK₨160.57 | 4.7% +PK₨2.0b | 142.7% | PE21.8x | |
| HINOON Highnoon Laboratories | PK₨912.05 | 3.0% +PK₨1.4b | 93.5% | PE16x | |
| MACTER Macter International | PK₨177.41 | 18.2% +PK₨1.3b | 105.4% | n/a |